A new editorial was published in Oncotarget’s Volume 15 on December 24, 2024, titled “Pitfalls and perils from FDA-approved germ-line cancer predisposition tests.”
OpenAI, Color Health Launch Cancer Copilot Tool To Expedite Cancer Treatment
What You Should Know: – Cancer – the second leading cause of death in the United States – is a complex disease requiring timely diagnosis
June 18, 2024